What is Oatmeal Health?
Oatmeal Health is a lung cancer screening platform that combines patient eligibility identification with investigational AI assessment of lung nodules. Oatmeal Health serves community health centers, hospitals, imaging centers, and health plans. The service connects organizations that have eligible patients with organizations that provide imaging and organizations that cover screening.
Oatmeal Health describes a screening gap caused partly by fragmented care and incomplete smoking histories. LungIQ addresses patient identification, while LungAI is designed to support radiologists reviewing nodules. These components have different roles, and LungAI remains an investigational medical device rather than a commercially available product in the United States.
What Oatmeal Health can do
Oatmeal Health organizes its capabilities around finding eligible patients and supporting nodule assessment. LungIQ searches electronic health records, including information outside structured fields. LungAI is designed to add a cancer risk score alongside existing radiology workflows. Oatmeal Health also describes referral connections and outcomes modeling for participating healthcare organizations.
- LungIQ identifies patients who qualify for lung cancer screening.
- LungIQ finds smoking history buried in free-text notes.
- Oatmeal Health refers eligible patients to partner imaging centers.
- LungAI assigns an investigational cancer risk score from 0 to 10 per nodule.
- LungAI is designed to display scores inside existing radiology viewers.
- Oatmeal Health builds health plan outcomes models with actuaries.
How Oatmeal Health works
Oatmeal Health starts the screening workflow with LungIQ scanning EHR data for eligible patients. Community health centers can identify candidates even when smoking history was not entered into structured fields. Eligible patients are referred to partner imaging centers, and hospitals can also use LungIQ to identify candidates within their own systems.
Oatmeal Health positions LungAI as an AI second opinion for radiologists, designed to work with Lung-RADS inside the viewer already in use. The stated workflow requires no new workstation or login. This describes the intended LungAI workflow; the website separately states that LungAI has not been cleared by FDA.
Who Oatmeal Health is for
Oatmeal Health targets organizations involved in lung cancer screening rather than individual consumers seeking a standalone diagnostic tool. Community health centers contribute access to patients, hospitals and imaging centers provide scanning, and health plans participate through covered screening benefits and outcomes modeling. Oatmeal Health describes programs for each of these organizational audiences.
- Community health centers can find eligible patients with incomplete structured smoking histories.
- Hospitals can identify screening candidates within their own patient records.
- Imaging centers can receive referrals from community health center partners.
- Health plans can model screening outcomes with their actuaries.
Oatmeal Health program access and LungAI availability
Oatmeal Health provides website pathways for community health centers, hospitals, health systems, and health plans to discuss organizational programs. LungAI has a separate availability restriction: the investigational device is not commercially available in the United States. Oatmeal Health states that a 510(k) premarket notification is being prepared for submission to FDA.
Oatmeal Health strengths and evidence limitations
Oatmeal Health combines eligibility discovery, referral connections, and investigational radiology support within a screening-focused service. LungIQ addresses missing structured smoking history by searching free-text notes. For LungAI, the existing-viewer design could fit established reading workflows, but the evidence and regulatory status limit how the reported results should be interpreted.
- LungAI has not been cleared by FDA.
- LungAI clinical performance data come from retrospective studies on held-out datasets.
- LungAI results may differ in prospective clinical use.
- The first public LungAI study is a preprint that is not yet peer reviewed.
Oatmeal Health FAQ
What is Oatmeal Health?
Oatmeal Health is a lung cancer screening platform for community health centers, hospitals, imaging centers, and health plans. Oatmeal Health combines LungIQ patient eligibility identification with LungAI, an investigational system designed to score lung nodule cancer risk.
Can Oatmeal Health find screening candidates with missing smoking history?
Oatmeal Health uses LungIQ to identify screening-eligible patients even when smoking history is absent from structured EHR fields. LungIQ searches free-text notes for smoking history that can help identify patients who qualify for screening.
Is Oatmeal Health's LungAI FDA cleared?
Oatmeal Health states that LungAI is investigational, has not been cleared by FDA, and is not commercially available in the United States. Oatmeal Health is preparing a 510(k) premarket notification for submission to FDA.
Does Oatmeal Health work inside existing radiology viewers?
Oatmeal Health describes LungAI as designed to show per-nodule cancer risk scores inside the viewer radiologists already use, without a new workstation or login. LungAI is intended to work with Lung-RADS but remains investigational.
What evidence supports Oatmeal Health's LungAI?
Oatmeal Health reports LungAI performance from retrospective studies on held-out datasets, including an NLST study released as a preprint. Oatmeal Health states that the preprint is not yet peer reviewed and that results may differ in prospective use.
From the community
No reviews yet
Be the first to review this tool. What you write helps the next person choose.




